Epigenetic signature helps predict risk of metastatic thyroid cancer progression

Researchers from the Endocrine Tumors group at the Germans Trias i Pujol Research Institute (IGTP), in collaboration with five university hospitals, have conducted the first comprehensive study of DNA methylation patterns in metastatic differentiated thyroid cancer (DTC).

See also  Aboriginal and Torres Strait Islander women and breast cancer
Total
0
Share
Need Help?